FBRX CIK: 1419041

Forte Biosciences, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.7
FY22:
−8.19
FY23:
−28.7
FY24:
−30.7
FY25:
−50.9
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
0.05
FY24:
−36.0
FY25:
36.2
Change from FY21 to FY25
millions USD
FY21:
−0.04
FY22:
7.24
FY23:
24.7
FY24:
51.9
FY25:
69.4
millions USD
FY21:
−16.7
FY22:
−0.94
FY23:
−3.98
FY24:
−14.9
FY25:
54.7
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−28.8
FY24:
−30.8
FY25:
−51.0

All amounts in millions USD Data source:SEC EDGAR